Plasma from patients with Vaccine-induced immune thrombotic thrombocytopenia displays increased fibrinolytic potential and enhances tPA but not uPA-mediated plasminogen activation
Description
BACKGROUND: Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare complication of adenovirus vector-based COVID-19 vaccines. VITT is associated with markedly raised levels of D-dimer yet how VITT modulates the fibrinolytic system is
